Gunawan, A. S., McLornan, D. P., Wilkins, B., Waghorn, K., Hoade, Y., Cross, N. C. P. and Harrison, C. N. (2017) “Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia”, Haematologica. Pavia, Italy, 102(6), pp. e238-e240. doi: 10.3324/haematol.2017.163790.